Showing results (31-40 of 389) with videos related to
Sort By:
Pageof 39
Molecular & Cellular Proteomics : MCP|September 4, 2012
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patientsOlesya Chornoguz, Alexei Gapeev, Michael C O'Neill, et al.Cancer Immunology, Immunotherapy : CII|May 7, 2005
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppressionPratima Sinha, Virginia K Clements, Seth Miller, et al.Cancer Research|May 8, 2007
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cellsPratima Sinha, Virginia K Clements, Amy M Fulton, et al.Journal of Proteome Research|December 4, 2013
Exosomes from myeloid-derived suppressor cells carry biologically active proteinsMeghan Burke, Waeowalee Choksawangkarn, Nathan Edwards, et al.Analytical Chemistry|November 1, 2016
Evaluation of Spectral Counting for Relative Quantitation of Proteoforms in Top-Down ProteomicsLucía Geis-Asteggiante, Suzanne Ostrand-Rosenberg, Catherine Fenselau, et al.Seminars in Cancer Biology|February 9, 2012
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppressionSuzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W Beury, et al.Cancer Immunology, Immunotherapy : CII|September 11, 2019
Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironmentSuzanne Ostrand-Rosenberg, Daniel W Beury, Katherine H Parker, et al.International Journal of Mass Spectrometry|May 5, 2015
Top-down analysis of low mass proteins in exosomes shed by murine myeloid-derived suppressor cellsLucía Geis-Asteggiante, Avantika Dhabaria, Nathan Edwards, et al.FEBS Letters|May 29, 2004
Immunotherapy and immunoselection -- tumour escape as the final hurdleGraham PawelecPageof 39